Pramipexole is a non-ergot dopamine agonist indicated for the symptomatic treatment of Parkinson's disease and moderate-to-severe restless legs syndrome. This therapeutic agent functions by binding selectively… Read more
![Chemical structure of Tert-butyl ((6S)-2-(((6S)-2-((tert-butoxycarbonyl)amino)-6-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-7-yl)amino)-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)(propyl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FTert-butyl-6S-2-6S-2-tert-butoxycarbonylamino-6-propylamino-4567-tetrahydrobenzodthiazol-7-ylamino-4567-tetrahydrobenzodthiazol-6-ylpropylcarbamate.png&w=3840&q=75)
![Chemical structure of tert-Butyl ((6S,7S)-2-acetamido-6-(N-propylacetamido)-4,5,6,7-tetrahydrobenzo[d]thiazol-7-yl)((S)-6-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-6S7S-2-acetamido-6-N-propylacetamido-4567-tetrahydrobenzodthiazol-7-ylS-6-propylamino-4567-tetrahydrobenzodthiazol-2-ylcarbamate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-(2-((hydroxymethyl)amino)-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)(propyl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-2-hydroxymethylamino-4567-tetrahydrobenzodthiazol-6-ylpropylcarbamate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-(2-((tert-butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)(propyl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-2-tert-butoxycarbonylamino-4567-tetrahydrobenzodthiazol-6-ylpropylcarbamate.png&w=3840&q=75)
![Chemical structure of Tert-butyl (S)-(2-((tert-butoxycarbonyl)amino)-7-oxo-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)(propyl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FTert-butyl-S-2-tert-butoxycarbonylamino-7-oxo-4567-tetrahydrobenzodthiazol-6-ylpropylcarbamate.png&w=3840&q=75)
![Chemical structure of Tert-butyl (S)-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)(propyl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FTert-butyl-S-2-amino-4567-tetrahydrobenzodthiazol-6-ylpropylcarbamate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-(2-formamido-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)(propyl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-S-2-formamido-4567-tetrahydrobenzodthiazol-6-ylpropylcarbamate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (S)-(2-propionamido-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)(propyl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1801878-54-5-tert-Butyl-S-2-propionamido-4567-tetrahydrobenzodthiazol-6-ylpropylcarbamate.png&w=3840&q=75)

Pramipexole is a non-ergot dopamine agonist indicated for the symptomatic treatment of Parkinson's disease and moderate-to-severe restless legs syndrome. This therapeutic agent functions by binding selectively to dopamine D2 and D3 receptors in the brain, helping to restore dopaminergic activity. To support pharmaceutical research and manufacturing, this category provides a comprehensive collection of reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope labelled compounds. Pharmaceutical laboratories utilize these materials for robust impurity profiling, rigorous method validation, and ongoing quality control of the active pharmaceutical ingredient. These highly characterized reference standards facilitate the accurate identification and quantification of process-related and degradation-related impurities, ensuring that drug formulations meet established safety and quality requirements throughout their product lifecycle.